FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2944743112> ?p ?o ?g. }

• W2944743112 endingPage "1124" @default.
• W2944743112 startingPage "1117" @default.
• W2944743112 abstract "Abstract Background African‐American (AA) men tend to present with more aggressive prostate cancer (Gleason score >7) than European‐American (EA) men. Vitamin D and its metabolites are implicated in prostate cancer biology with vitamin D deficiency, indicated by its metabolite levels in serum or plasma, usually observed in AA men. Objective To determine if 1, 25‐dihydroxy vitamin D3 [1,25(OH) 2 D] plasma levels in AA and EA prostate cancer patients alter the risk of having aggressive prostate cancer. Design Research subjects from the North Carolina‐Louisiana Prostate Cancer Project (AA n = 435 and EA n = 532) were included. Plasma metabolites 1,25(OH) 2 D and 25‐hydroxyvitamin D3 [25(OH)D] were measured using liquid chromatography with tandem mass spectrophotometry. Research subjects were classified into low (Gleason sum < 7, stage T1‐T2, and Prostate‐specific antigen (PSA) < 9 ng/mL) or high (Gleason sum > 8 or Gleason sum = 7 with 4 + 3, or PSA > 20 ng/mL, or Gleason sum = 7 and stage T3‐T4) aggressive disease. Results Research subjects in the second and third tertiles of plasma levels of 1, 25(OH) 2 D had lower odds of high aggressive prostate cancer (AA [OR T2vsT1 : 0.66, 95%CI: 0.39‐1.12; OR T3vsT1 : 0.83, 95%CI: 0.49‐1.41] and EA [OR T2vsT1 : 0.68, 95%CI: 0.41‐1.11; OR T3vsT1 : 0.67, 95%CI: 0.40‐1.11]) compared with the first tertile, though confidence intervals included the null. Greater 1,25(OH) 2 D/25(OH)D molar ratios were associated with lower odds of high aggressive prostate cancer more evidently in AA (OR Q4vsQ1 : 0.45, CI: 0.24‐0.82) than in EA (OR Q4vsQ1 : 0.64, CI: 0.35‐1.17) research subjects. Conclusions The 1,25(OH) 2 D/25(OH)D molar ratio was associated with decreased risk of high aggressive prostate cancer in AA men, and possibly in EA men. Further studies analyzing vitamin D polymorphisms, vitamin D binding protein levels, and prostatic levels of these metabolites may be useful. These studies may provide a better understanding of the vitamin D pathway and its biological role underlying health disparities in prostate cancer." @default.
• W2944743112 created "2019-05-16" @default.
• W2944743112 creator A5002287326 @default.
• W2944743112 creator A5021958104 @default.
• W2944743112 creator A5043674257 @default.
• W2944743112 creator A5043755272 @default.
• W2944743112 creator A5051726130 @default.
• W2944743112 creator A5052870503 @default.
• W2944743112 creator A5053336377 @default.
• W2944743112 creator A5057901093 @default.
• W2944743112 creator A5058499570 @default.
• W2944743112 creator A5074919849 @default.
• W2944743112 creator A5081220639 @default.
• W2944743112 date "2019-05-11" @default.
• W2944743112 modified "2023-10-15" @default.
• W2944743112 title "Association among plasma 1,25(OH)₂D, ratio of 1,25(OH)₂D to 25(OH)D, and prostate cancer aggressiveness" @default.
• W2944743112 cites W1575744648 @default.
• W2944743112 cites W1893905983 @default.
• W2944743112 cites W1956824670 @default.
• W2944743112 cites W1970258257 @default.
• W2944743112 cites W1974092422 @default.
• W2944743112 cites W1983620628 @default.
• W2944743112 cites W1985044546 @default.
• W2944743112 cites W1994134731 @default.
• W2944743112 cites W2011528548 @default.
• W2944743112 cites W2014974546 @default.
• W2944743112 cites W2024069889 @default.
• W2944743112 cites W2025857779 @default.
• W2944743112 cites W2032512576 @default.
• W2944743112 cites W2048952687 @default.
• W2944743112 cites W2078234618 @default.
• W2944743112 cites W2084388232 @default.
• W2944743112 cites W2085491680 @default.
• W2944743112 cites W2091214366 @default.
• W2944743112 cites W2095385698 @default.
• W2944743112 cites W2110465545 @default.
• W2944743112 cites W2120559691 @default.
• W2944743112 cites W2124371831 @default.
• W2944743112 cites W2125577640 @default.
• W2944743112 cites W2127979105 @default.
• W2944743112 cites W2149699257 @default.
• W2944743112 cites W2151063703 @default.
• W2944743112 cites W2155354626 @default.
• W2944743112 cites W2157698829 @default.
• W2944743112 cites W2171424523 @default.
• W2944743112 cites W2278216384 @default.
• W2944743112 cites W2567248794 @default.
• W2944743112 cites W2572323937 @default.
• W2944743112 cites W2574051342 @default.
• W2944743112 cites W2577216091 @default.
• W2944743112 cites W2580558361 @default.
• W2944743112 cites W2605227526 @default.
• W2944743112 cites W2606108784 @default.
• W2944743112 cites W2608458214 @default.
• W2944743112 cites W2899572198 @default.
• W2944743112 cites W2900292544 @default.
• W2944743112 cites W2944743112 @default.
• W2944743112 doi "https://doi.org/10.1002/pros.23824" @default.
• W2944743112 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6593756" @default.
• W2944743112 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31077420" @default.
• W2944743112 hasPublicationYear "2019" @default.
• W2944743112 type Work @default.
• W2944743112 sameAs 2944743112 @default.
• W2944743112 citedByCount "17" @default.
• W2944743112 countsByYear W29447431122019 @default.
• W2944743112 countsByYear W29447431122020 @default.
• W2944743112 countsByYear W29447431122021 @default.
• W2944743112 countsByYear W29447431122022 @default.
• W2944743112 countsByYear W29447431122023 @default.
• W2944743112 crossrefType "journal-article" @default.
• W2944743112 hasAuthorship W2944743112A5002287326 @default.
• W2944743112 hasAuthorship W2944743112A5021958104 @default.
• W2944743112 hasAuthorship W2944743112A5043674257 @default.
• W2944743112 hasAuthorship W2944743112A5043755272 @default.
• W2944743112 hasAuthorship W2944743112A5051726130 @default.
• W2944743112 hasAuthorship W2944743112A5052870503 @default.
• W2944743112 hasAuthorship W2944743112A5053336377 @default.
• W2944743112 hasAuthorship W2944743112A5057901093 @default.
• W2944743112 hasAuthorship W2944743112A5058499570 @default.
• W2944743112 hasAuthorship W2944743112A5074919849 @default.
• W2944743112 hasAuthorship W2944743112A5081220639 @default.
• W2944743112 hasBestOaLocation W29447431121 @default.
• W2944743112 hasConcept C121608353 @default.
• W2944743112 hasConcept C124490489 @default.
• W2944743112 hasConcept C126322002 @default.
• W2944743112 hasConcept C126894567 @default.
• W2944743112 hasConcept C134018914 @default.
• W2944743112 hasConcept C156957248 @default.
• W2944743112 hasConcept C2776235491 @default.
• W2944743112 hasConcept C2777477808 @default.
• W2944743112 hasConcept C2780192828 @default.
• W2944743112 hasConcept C2781406297 @default.
• W2944743112 hasConcept C44249647 @default.
• W2944743112 hasConcept C71924100 @default.
• W2944743112 hasConcept C90924648 @default.
• W2944743112 hasConceptScore W2944743112C121608353 @default.
• W2944743112 hasConceptScore W2944743112C124490489 @default.
• W2944743112 hasConceptScore W2944743112C126322002 @default.

• next